Use of Patiromer to transition chronic kidney disease patients with hyperkalemia to a plant-rich diet.
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Chronic Kidney Disease, Stages 3b-4Mild Hyperkalemia (potassium 5.1 To
-
Age: Between 19 years - 80 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Stages 3B-4 CKD
- No prior treatment with patiromer
- Mild hyperkalemia (potassium 5.1 to 6.5 mEq/L) on one of the last two blood tests
- No prior episodes of moderate-severe hyperkalemia (potassium >6.5 mEq/L)
- Deemed appropriate for the intervention by the your nephrologist
You may not be eligible for this study if the following are true:
-
- Recent change in medications that affect blood potassium concentrations
- Diagnosed with bowel diseases or syndromes (e.g., bowel obstruction, major GI surgery, short-bowel syndrome, irritable bowel syndrome, inflammatory bowel disease, chronic diarrhea)
- Diagnosed with swallowing disorders
- Unable to separate patiromer dose from other medications by 6 hours
- Dietary restrictions (e.g., allergies) or otherwise unable/unwilling to adhere to study diets (excludes dietary restrictions on high-potassium foods)
- Pregnant (females) or planning to become pregnant (males and females) during the study
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.